INVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Innoviva, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$21.08+0.30 (+1.44%)
Close on Oct 19, 2026
- Market cap
- $1.55B
- P/E (TTM)
- 5.2
- Dividend yield
- –
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
–
Consecutive increases
0 years
Not raised last year
Five-year growth
–
Per year, per share
Payout ratio, FY2025
–
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | – | – | – | – |
| FY2024 | – | – | – | – |
| FY2023 | – | – | – | – |
| FY2022 | – | – | – | – |
| FY2021 | – | – | $0 | – |
| FY2020 | – | – | $0 | – |
| FY2019 | – | – | $11.00K | – |
| FY2018 | – | – | $80.00K | – |
| FY2017 | $0.00 | – | $281.00K | – |
| FY2016 | $0.00 | -100.0% | $960.00K | – |
| FY2015 | $0.75 | +50.0% | $87.33M | – |
| FY2014 | $0.50 | – | $56.99M | – |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.